骨关节炎及其药物治疗的最佳选择

[1] Opioid therapy for osteoarthritis of the hip and knee: use it for lose it. Peloso PM. The Journal of Rheumatology . 2001

[2] Recommendations for the Medical management of osteoarthritis of the hip and knee.2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Altman RD,Hochberg MC,Moskowitz KW,et al. Arthritis and Rheumatism . 2000

[3] Renal failure associated with the use of celecoxib and rofecoxib. Ahmad SR,Kortepeter C,Brinker A,et al. Drug Safety . 2002

[4] Efficacy and safety of diacerein in osteoarthritis of the knee: a double- blind, placebo- controlled trial.The Diacerein Study Group. Pelletier JP,Yaron M,Haraoui B,et al. Arthritis and Rheumatism . 2000

[5] Diacerhein and rhein prevent interleukin-1 beta induced nuclear factor-kappa B activation by inhibiting the degradation of inhibitor kappa B-alpha. Mendes AF,Caramona MM,Carvalho AP,et al. Pharmacology and Toxicology . 2002

[6] Glucosamine sulfate use and delay of progression of knee osteoarthritis. Pavelka K,Catterovd J,Olejarovd M,et al. Archives of Internal Medicine . 2002

[7] Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebocontrolled clinical trial. Reginster JY,Deroisy R,Rovati LC,et al. The Lancet . 2001

[1] Opioid therapy for osteoarthritis of the hip and knee: use it for lose it. Peloso PM. The Journal of Rheumatology . 2001

[2] Recommendations for the Medical management of osteoarthritis of the hip and knee.2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Altman RD,Hochberg MC,Moskowitz KW,et al. Arthritis and Rheumatism . 2000

[3] Renal failure associated with the use of celecoxib and rofecoxib. Ahmad SR,Kortepeter C,Brinker A,et al. Drug Safety . 2002

[4] Efficacy and safety of diacerein in osteoarthritis of the knee: a double- blind, placebo- controlled trial.The Diacerein Study Group. Pelletier JP,Yaron M,Haraoui B,et al. Arthritis and Rheumatism . 2000

[5] Diacerhein and rhein prevent interleukin-1 beta induced nuclear factor-kappa B activation by inhibiting the degradation of inhibitor kappa B-alpha. Mendes AF,Caramona MM,Carvalho AP,et al. Pharmacology and Toxicology . 2002

[6] Glucosamine sulfate use and delay of progression of knee osteoarthritis. Pavelka K,Catterovd J,Olejarovd M,et al. Archives of Internal Medicine . 2002

[7] Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebocontrolled clinical trial. Reginster JY,Deroisy R,Rovati LC,et al. The Lancet . 2001